Lv11
48 积分 2024-06-03 加入
2608-P: Efficacy and Safety of DA-302168S, a Novel Oral GLP-1 Receptor Agonist, in Chinese Adults with Overweight or Obesity: A Phase 2 Trial
3小时前
求助中
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
2个月前
已完结
Incidence and precursors of hypertension in young adults: The Framingham offspring study
2个月前
已完结
Epidemiology and determinants of obesity in China
2个月前
已完结
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association
2个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
6个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
7个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1年前
已完结
Nonlinear dendritic integration of sensory and motor input during an active sensing task
1年前
已完结
皖公网安备34019202002308
